Clinical trial
Phosphorus 32 in Treating Patients With Glioblastoma Multiforme
NCT00004129 · Center for Molecular Medicine, Other · Unknown status
Key facts
| NCT number | NCT00004129 |
|---|---|
| Title | Phosphorus 32 in Treating Patients With Glioblastoma Multiforme |
| Official title | Phase I/II Study of Interstitial Colloidal 32P for the Treatment of Recurrent Malignant Central Nervous System Tumors and Primary Central Nervous System Tumors With Poor Prognostic Factors |
| Lead sponsor | Center for Molecular Medicine, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Radiation |
| Interventions | brachytherapy, phosphorus P32 |
| Enrollment | 12 |
| Start date | Sep 1, 1999 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 17, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: